US Stock MarketDetailed Quotes

ATAI ATAI Life Sciences

Watchlist
  • 1.270
  • -0.010-0.78%
Close Jul 5 16:00 ET
212.61MMarket Cap-6047P/E (TTM)

ATAI Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.93%-22.57M
19.48%-84.12M
28.01%-21.96M
34.28%-18.43M
-3.11%-22.61M
11.99%-21.11M
-65.18%-104.47M
-48.74%-30.51M
0.23%-28.05M
-1,256.09%-21.93M
Net income from continuing operations
20.31%-27.38M
72.12%-43.9M
58.97%-19.14M
221.49%43.37M
9.96%-33.77M
8.53%-34.35M
9.66%-157.42M
49.99%-46.65M
-12.83%-35.7M
29.72%-37.51M
Operating gains losses
1.61%1.9M
-54.74%4.33M
-87.10%578K
98.03%-42K
-38.62%1.93M
-54.26%1.87M
-64.27%9.57M
-90.27%4.48M
38.08%-2.13M
117.99%3.15M
Depreciation and amortization
27.69%83K
89.88%319K
90.57%101K
105.56%74K
315.79%79K
8.33%65K
257.45%168K
82.76%53K
614.29%36K
0.00%19K
Deferred tax
----
--0
----
----
----
----
--5.07M
----
----
----
Other non cash items
306.24%2.08M
-4,816.63%-86.34M
-5,969.09%-86.79M
191.63%416K
455.85%1.05M
-1,581.67%-1.01M
-110.94%-1.76M
-123.12%-1.43M
2.58%-454K
-98.02%188K
Change In working capital
-236.99%-5.01M
323.96%7.47M
165.19%2.64M
902.94%341K
-60.97%831K
351.89%3.66M
56.14%-3.34M
-1,555.04%-4.05M
100.70%34K
-89.49%2.13M
-Change in prepaid assets
-99.71%14K
669.19%8.66M
660.55%1.95M
60.18%-1.08M
31.28%2.93M
478.04%4.87M
84.31%-1.52M
709.52%256K
65.97%-2.72M
1,502.88%2.23M
-Change in payables and accrued expense
-314.51%-5.03M
34.14%-1.19M
116.04%690K
-48.27%1.42M
-2,015.15%-2.09M
-639.63%-1.21M
-122.50%-1.81M
-166.57%-4.3M
-10.13%2.75M
-177.95%-99K
Cash from discontinued investing activities
Operating cash flow
-6.93%-22.57M
19.48%-84.12M
28.01%-21.96M
34.28%-18.43M
-3.11%-22.61M
11.99%-21.11M
-65.18%-104.47M
-48.74%-30.51M
0.23%-28.05M
-1,256.09%-21.93M
Investing cash flow
Cash flow from continuing investing activities
-28.38%11.47M
38.63%-53.3M
-101.03%-824K
-170.38%-46.49M
-20.81%-22.01M
107.46%16.02M
-6.86%-86.85M
264.60%80.05M
10,857.33%66.05M
35.66%-18.21M
Capital expenditure reported
96.93%-5K
-31.87%-331K
88.89%-9K
97.14%-2K
-57.00%-157K
---163K
73.72%-251K
73.44%-81K
85.86%-70K
---100K
Net PPE purchase and sale
--0
66.49%-259K
94.37%-8K
--0
125.00%29K
-400.00%-280K
-346.82%-773K
-173.08%-142K
-359.32%-459K
5.69%-116K
Net business purchase and sale
----
---443K
--37K
----
----
----
--0
--0
----
----
Net investment purchase and sale
-35.89%12.48M
43.56%-46.75M
-99.78%173K
-166.85%-44.51M
-21.55%-21.88M
109.19%19.46M
-250.09%-82.82M
8,027,400.00%80.28M
31,211.68%66.58M
20.65%-18M
Net other investing changes
66.63%-1M
-83.77%-5.51M
---1.02M
---1.5M
--0
0.00%-3M
15.56%-3M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-28.39%11.47M
38.63%-53.3M
-101.03%-823K
-170.38%-46.49M
-20.81%-22.01M
107.46%16.02M
-6.86%-86.85M
264.60%80.05M
10,857.33%66.05M
35.66%-18.21M
Financing cash flow
Cash flow from continuing financing activities
0
-140.20%-8.36M
-817.68%-8.46M
0
-105.57%-100K
56.06%206K
-94.93%20.79M
-153.51%-922K
410.21%19.78M
-99.52%1.79M
Net issuance payments of debt
----
--0
--0
----
----
----
844.58%15M
--0
----
----
Net preferred stock issuance
----
--0
--0
--0
----
----
--600K
--0
--0
----
Proceeds from stock option exercised by employees
--0
-91.06%205K
-100.81%-1K
--0
--0
56.06%206K
56.16%2.29M
-86.84%123K
--1.92M
--117K
Net other financing activities
----
-396.09%-8.56M
-709.57%-8.46M
--0
----
----
193.89%2.89M
-232.78%-1.05M
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-140.20%-8.36M
-817.68%-8.46M
--0
-105.57%-100K
56.06%206K
-94.93%20.79M
-153.51%-922K
410.21%19.78M
-99.52%1.79M
Net cash flow
Beginning cash position
-76.37%45.03M
-47.38%190.61M
-46.34%76.49M
67.70%141.09M
49.94%185.89M
-47.38%190.61M
272.53%362.27M
-66.88%142.54M
-81.45%84.13M
18.79%123.98M
Current changes in cash
-127.19%-11.1M
14.52%-145.77M
-164.26%-31.25M
-212.34%-64.92M
-16.60%-44.72M
97.95%-4.89M
-164.27%-170.53M
172.12%48.63M
332.57%57.79M
-111.04%-38.35M
Effect of exchange rate changes
-140.25%-64K
116.83%189K
61.52%-212K
-48.79%318K
94.91%-76K
-46.82%159K
-250.94%-1.12M
11.56%-551K
-59.49%621K
-178.49%-1.49M
End cash Position
-81.78%33.87M
-76.37%45.03M
-76.37%45.03M
-46.34%76.49M
67.70%141.09M
49.94%185.89M
-47.38%190.61M
-47.38%190.61M
-66.88%142.54M
-81.45%84.13M
Free cash flow
-4.75%-22.58M
19.70%-84.71M
28.47%-21.98M
35.49%-18.43M
-2.69%-22.74M
10.35%-21.55M
-63.87%-105.49M
-47.26%-30.73M
-0.51%-28.57M
-1,467.94%-22.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.93%-22.57M19.48%-84.12M28.01%-21.96M34.28%-18.43M-3.11%-22.61M11.99%-21.11M-65.18%-104.47M-48.74%-30.51M0.23%-28.05M-1,256.09%-21.93M
Net income from continuing operations 20.31%-27.38M72.12%-43.9M58.97%-19.14M221.49%43.37M9.96%-33.77M8.53%-34.35M9.66%-157.42M49.99%-46.65M-12.83%-35.7M29.72%-37.51M
Operating gains losses 1.61%1.9M-54.74%4.33M-87.10%578K98.03%-42K-38.62%1.93M-54.26%1.87M-64.27%9.57M-90.27%4.48M38.08%-2.13M117.99%3.15M
Depreciation and amortization 27.69%83K89.88%319K90.57%101K105.56%74K315.79%79K8.33%65K257.45%168K82.76%53K614.29%36K0.00%19K
Deferred tax ------0------------------5.07M------------
Other non cash items 306.24%2.08M-4,816.63%-86.34M-5,969.09%-86.79M191.63%416K455.85%1.05M-1,581.67%-1.01M-110.94%-1.76M-123.12%-1.43M2.58%-454K-98.02%188K
Change In working capital -236.99%-5.01M323.96%7.47M165.19%2.64M902.94%341K-60.97%831K351.89%3.66M56.14%-3.34M-1,555.04%-4.05M100.70%34K-89.49%2.13M
-Change in prepaid assets -99.71%14K669.19%8.66M660.55%1.95M60.18%-1.08M31.28%2.93M478.04%4.87M84.31%-1.52M709.52%256K65.97%-2.72M1,502.88%2.23M
-Change in payables and accrued expense -314.51%-5.03M34.14%-1.19M116.04%690K-48.27%1.42M-2,015.15%-2.09M-639.63%-1.21M-122.50%-1.81M-166.57%-4.3M-10.13%2.75M-177.95%-99K
Cash from discontinued investing activities
Operating cash flow -6.93%-22.57M19.48%-84.12M28.01%-21.96M34.28%-18.43M-3.11%-22.61M11.99%-21.11M-65.18%-104.47M-48.74%-30.51M0.23%-28.05M-1,256.09%-21.93M
Investing cash flow
Cash flow from continuing investing activities -28.38%11.47M38.63%-53.3M-101.03%-824K-170.38%-46.49M-20.81%-22.01M107.46%16.02M-6.86%-86.85M264.60%80.05M10,857.33%66.05M35.66%-18.21M
Capital expenditure reported 96.93%-5K-31.87%-331K88.89%-9K97.14%-2K-57.00%-157K---163K73.72%-251K73.44%-81K85.86%-70K---100K
Net PPE purchase and sale --066.49%-259K94.37%-8K--0125.00%29K-400.00%-280K-346.82%-773K-173.08%-142K-359.32%-459K5.69%-116K
Net business purchase and sale -------443K--37K--------------0--0--------
Net investment purchase and sale -35.89%12.48M43.56%-46.75M-99.78%173K-166.85%-44.51M-21.55%-21.88M109.19%19.46M-250.09%-82.82M8,027,400.00%80.28M31,211.68%66.58M20.65%-18M
Net other investing changes 66.63%-1M-83.77%-5.51M---1.02M---1.5M--00.00%-3M15.56%-3M--0--0--0
Cash from discontinued investing activities
Investing cash flow -28.39%11.47M38.63%-53.3M-101.03%-823K-170.38%-46.49M-20.81%-22.01M107.46%16.02M-6.86%-86.85M264.60%80.05M10,857.33%66.05M35.66%-18.21M
Financing cash flow
Cash flow from continuing financing activities 0-140.20%-8.36M-817.68%-8.46M0-105.57%-100K56.06%206K-94.93%20.79M-153.51%-922K410.21%19.78M-99.52%1.79M
Net issuance payments of debt ------0--0------------844.58%15M--0--------
Net preferred stock issuance ------0--0--0----------600K--0--0----
Proceeds from stock option exercised by employees --0-91.06%205K-100.81%-1K--0--056.06%206K56.16%2.29M-86.84%123K--1.92M--117K
Net other financing activities -----396.09%-8.56M-709.57%-8.46M--0--------193.89%2.89M-232.78%-1.05M--------
Cash from discontinued financing activities
Financing cash flow --0-140.20%-8.36M-817.68%-8.46M--0-105.57%-100K56.06%206K-94.93%20.79M-153.51%-922K410.21%19.78M-99.52%1.79M
Net cash flow
Beginning cash position -76.37%45.03M-47.38%190.61M-46.34%76.49M67.70%141.09M49.94%185.89M-47.38%190.61M272.53%362.27M-66.88%142.54M-81.45%84.13M18.79%123.98M
Current changes in cash -127.19%-11.1M14.52%-145.77M-164.26%-31.25M-212.34%-64.92M-16.60%-44.72M97.95%-4.89M-164.27%-170.53M172.12%48.63M332.57%57.79M-111.04%-38.35M
Effect of exchange rate changes -140.25%-64K116.83%189K61.52%-212K-48.79%318K94.91%-76K-46.82%159K-250.94%-1.12M11.56%-551K-59.49%621K-178.49%-1.49M
End cash Position -81.78%33.87M-76.37%45.03M-76.37%45.03M-46.34%76.49M67.70%141.09M49.94%185.89M-47.38%190.61M-47.38%190.61M-66.88%142.54M-81.45%84.13M
Free cash flow -4.75%-22.58M19.70%-84.71M28.47%-21.98M35.49%-18.43M-2.69%-22.74M10.35%-21.55M-63.87%-105.49M-47.26%-30.73M-0.51%-28.57M-1,467.94%-22.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg